Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy. - Wikidata - awgldk - TriplyDB

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

http://www.wikidata.org/entity/Q36804366

about

Immune cell screening of a nanoparticle library improves atherosclerosis therapy Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Applying nanomedicine in maladaptive inflammation and angiogenesis.Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle Formulations.Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.Imaging-guided revival of nanomedicine?Integrating nanomedicine and imaging.Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.Near-Infrared Quantum Dot and 89Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov Imaging.pH-Responsive Nanoscale Coordination Polymer for Efficient Drug Delivery and Real-Time Release Monitoring.A Step-by-Step Multiple Stimuli-Responsive Nanoplatform for Enhancing Combined Chemo-Photodynamic Therapy.Combinatorial approaches in post-polymerization modification for rational development of therapeutic delivery systems.Reversible glycosidic switch for secure delivery of molecular nanocargos.Quantifying Release from Lipid Nanocarriers by Fluorescence Correlation Spectroscopy

P2860

Q28393434-6B3B539A-467C-4B69-95C4-343A6F503715 Q30362001-3B4ECC1D-4E4B-487A-8E4E-31DD7A4BD08A Q38557650-446FEA64-AE97-4FCD-AD0F-3A67B2B073D4 Q41303888-B8C2F6DC-09EF-4564-B301-5D7A3DC5067D Q41662449-FF759349-C7A1-48F3-9E81-7271EB8D59E8 Q43095122-7C2879C4-298F-4ED1-A14A-058043005DB9 Q47115988-71AD4825-D10E-4582-AD69-1E9211A3BBFF Q47313459-42312BAB-26CF-4D31-BC93-0CAFC601B6AB Q48049192-C1E74F8B-F2B5-4F32-8AC3-56DA5DB44289 Q48115096-B7209C34-99E8-4C9D-9C23-7F7DF8C90751 Q48117650-E857FA9D-BACA-4F9D-8493-415C3892469E Q51026986-53A6B6AC-3CEB-45EF-949B-4B5643B5D626 Q52588639-8EE8FB2F-02AC-40A5-BB5A-2582B0FA4BCF Q55329893-3496604A-A045-4785-9A14-D598DDE9BD90 Q58580894-357DD1C4-D93F-4F25-A16B-CB84077606EE

P2860

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

http://www.wikidata.org/entity/Q36804366

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@ast

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@en

type

label

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@ast

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@en

prefLabel

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@ast

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@en

P1433

Q36804366-429EBB1E-BADB-46C3-8CE4-99D338A4C902

P1476

Q36804366-205E0872-8D17-4F99-B2FC-1CBC442A99DF

P2093

Q36804366-0221DC39-1733-4B93-B468-8F6210746AD1

Q36804366-60D147C1-B993-4991-8E86-7FE6436416E2

Q36804366-842C5E47-1A74-4F0A-A639-3C7D01665DDC

Q36804366-A7028341-FBBF-4D2A-AD28-650C7EAB3CAE

Q36804366-CE1F2168-5FDE-4507-B63B-14F82220E638

Q36804366-CE9F738C-1D47-411C-9648-24A569C33B02

Q36804366-FD822981-65DF-407E-8A42-F7660BCDB482

P2860

Q36804366-0E924C94-58BA-4FEB-98CE-71E04B060404

Q36804366-1042E6F4-80EC-434E-A593-18E044940CB4

Q36804366-109D207A-8F99-4422-8093-061B2D86E7D7

Q36804366-12937D85-F560-4F36-9A03-F556E3AE0163

Q36804366-16B96C9D-3559-4EF1-8BFE-8EFE468F47D0

Q36804366-1AC79544-3E54-46A6-A107-404EC9FFDF59

Q36804366-1EF55ED2-3BE2-4DF7-B990-06AD5E6D742B

Q36804366-24F6D3DE-B9CE-4A61-8907-7344B8306032

Q36804366-273D6B44-AE61-4A30-A662-E4ACE79C8AD5

Q36804366-32332265-6CC5-4B00-8C0C-7CF899832327

P2888

Q36804366-24693280-44F5-46F9-BDAA-3B74AA375D02

P304

Q36804366-787035AB-7EC1-4EC9-951B-82ACDA7F3A30

P31

Q36804366-D3C18356-B829-4EA7-B91F-E25D42F0F382

P356

Q36804366-DD9FBB7D-12EB-4093-9B1B-9EF0A23F4C65

P407

Q36804366-E39A978C-5E61-49AE-B987-40994744DFD1

P478

Q36804366-7104F26B-E5E6-4EE2-8BA0-723A915EE872

P50

Q36804366-0A2B2BE3-6891-49C8-B250-10372C545140

Q36804366-203D939A-A6D6-4369-B7E1-A8CD43D0F889

Q36804366-437C995F-5F39-431F-B19D-C2B131A00E53

Q36804366-5EF5C60D-73B8-49EF-9FFF-CBC9E12C1279

Q36804366-B18876F8-9E86-4772-B134-E9BEDC884C55

Q36804366-F59A3A9D-8917-478B-BC1B-293D916041FE

P577

Q36804366-36420DD8-BCBC-451D-83AA-C7CF2E53AF6F

P6179

Q36804366-8E1F8CD9-0EC4-485A-AEC6-D4A4E0619FA3

P698

Q36804366-BF67AA63-A0BE-4FE1-B64E-FBAAB4243A63

P932

Q36804366-93765EB3-F421-4C7F-B431-24393768F29E

P356

P1433

Nature Communications

P1476

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

@en

P2093

Astrid Bjørkøy

http://www.w3.org/2001/XMLSchema#string

Brandon Goode

http://www.w3.org/2001/XMLSchema#string

Brenda L Sanchez-Gaytan

http://www.w3.org/2001/XMLSchema#string

Catharina de Lange Davies

http://www.w3.org/2001/XMLSchema#string

Jose Manuel Perez-Aguilar

http://www.w3.org/2001/XMLSchema#string

Yiming Zhao

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding biophysicochemical interactions at the nano-bio interface

CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields

A holistic approach to targeting disease with polymeric nanoparticles

Scalable molecular dynamics with NAMD

Nanoparticle therapeutics: an emerging treatment modality for cancer

Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations.

The Rule of Five revisited: applying log D in place of log P in drug-likeness filters.

Spatiotemporal controlled delivery of nanoparticles to injured vasculature

Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection

Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.

P2888

P304

11221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS11221

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Pérez-Medina

Raphael Duivenvoorden

Harel Weinstein

Willem J.M. Mulder

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030202257

http://www.w3.org/2001/XMLSchema#string

P698

27071376

http://www.w3.org/2001/XMLSchema#string

P932

4833858

http://www.w3.org/2001/XMLSchema#string